 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Aug 14, 2024 |
| Title |
BIO 300 attenuates whole blood transcriptome changes in mice exposed to total-body radiation |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Development of radiation medical countermeasures under the U.S. Food and Drug Administration Animal Rule requires the capability to translate an effective animal to human drug dose. One method of human dose translation is using a biomarker and determining drug doses that modulate the biomarker to the desired level. BIO 300 Oral Powder (BIO 300) is a prophylactic radiation medical countermeasure that is currently being developed following the Animal Rule. The present study aimed to identify biomarkers that can be used for human dose conversion by conducting transcriptomics of whole blood collected from BIO 300-treated CD2F1 mice in the presence and absence of total-body irradiation (TBI). Mice were treated with vehicle or 50, 100 or 200 mg/kg BIO 300, twice daily, for 6 days. Whole blood samples were collected 24 and 48 h after the last dose of the drug. Animals were also treated with vehicle or 200 mg/kg BIO 300 for 6 days prior to 9.2 Gy TBI 24 h after the last dose, with blood collection 24 h after irradiation. RNA sequencing demonstrated 100 – 200 mg/kg doses caused significantly more differential gene expression at 48 h post-drug dose compared to 50 mg/kg. Pathway analysis of the transcriptome profile from vehicle-treated/radiation-exposed mice revealed that many inflammatory signaling pathways were activated in these animals. Signaling pathways enriched in BIO 300-treated/TBI mice were involved in cellular stress and immune response and were predicted to be inhibited. We also identified pathways that were in inverse states (activation/inhibition) in vehicle and BIO 300-treated mice with TBI. There were two pathways specifically activated in vehicle-treated animals with TBI and inhibited in BIO 300-treated animals (with or without TBI), pathogen-induced cytokine storm signaling and S100 family signaling. In comparison to previously published human data, pulmonary fibrosis idiopathic signaling and wound healing signaling were enriched in healthy volunteers treated with BIO 300 and BIO 300-treated mice with TBI. In all, four signaling pathways were identified that were activated in vehicle-treated animals exposed to total body radiation but inhibited in irradiated animals or healthy humans treated with BIO 300. These pathways should be explored to identify potential biomarkers of BIO 300 that can be used for human dose translation.
|
| |
|
| Overall design |
To investigate gene expression changes in unirradiated and irradiated mice treated with vehicle or one of three doses (low, med, high) of BIO 300. Changes in BIO 300-treatment groups were compared relative to vehicle groups. Each group included six mice that were terminal bled to collect whole blood for RNA sequencing.
|
| Web link |
https://www.mdpi.com/1422-0067/25/16/8818
|
| |
|
| Contributor(s) |
Serebrenik A, Fatanmi O, Wise S, Petrus S, Kaytor M, Singh V |
| Citation(s) |
39201502 |
| |
| Submission date |
May 23, 2024 |
| Last update date |
Sep 30, 2024 |
| Contact name |
Artur Serebrenik |
| E-mail(s) |
aserebrenik@humaneticscorp.com
|
| Organization name |
Humanetics Corporation
|
| Street address |
7760 France Ave S, Suite 920
|
| City |
Minneapolis |
| State/province |
MN |
| ZIP/Postal code |
55435 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
| Samples (60)
|
| GSM8288585 |
Mouse, Vehicle, Day0_16 |
| GSM8288586 |
Mouse, Vehicle, Day0_17 |
| GSM8288587 |
Mouse, Vehicle, Day0_18 |
| GSM8288588 |
Mouse, Vehicle, Day1_25 |
| GSM8288589 |
Mouse, Vehicle, Day1_26 |
| GSM8288590 |
Mouse, Vehicle, Day1_27 |
| GSM8288591 |
Mouse, Vehicle, Day1_28 |
| GSM8288592 |
Mouse, Vehicle, Day1_29 |
| GSM8288593 |
Mouse, Vehicle, Day1_30 |
| GSM8288594 |
Mouse, BIO300-Low, Day0_1 |
| GSM8288595 |
Mouse, BIO300-Low, Day0_2 |
| GSM8288596 |
Mouse, BIO300-Low, Day0_3 |
| GSM8288597 |
Mouse, BIO300-Low, Day0_4 |
| GSM8288598 |
Mouse, BIO300-Low, Day0_5 |
| GSM8288599 |
Mouse, BIO300-Low, Day0_6 |
| GSM8288600 |
Mouse, BIO300-Med, Day0_7 |
| GSM8288601 |
Mouse, BIO300-Med, Day0_8 |
| GSM8288602 |
Mouse, BIO300-Med, Day0_9 |
| GSM8288603 |
Mouse, BIO300-Med, Day0_10 |
| GSM8288604 |
Mouse, BIO300-Med, Day0_11 |
| GSM8288605 |
Mouse, BIO300-Med, Day0_12 |
| GSM8288606 |
Mouse, BIO300-High, Day0_19 |
| GSM8288607 |
Mouse, BIO300-High, Day0_20 |
| GSM8288608 |
Mouse, BIO300-High, Day0_21 |
| GSM8288609 |
Mouse, BIO300-High, Day0_22 |
| GSM8288610 |
Mouse, BIO300-High, Day0_23 |
| GSM8288611 |
Mouse, BIO300-High, Day0_24 |
| GSM8288612 |
Mouse, BIO300-Low, Day1_31 |
| GSM8288613 |
Mouse, BIO300-Low, Day1_32 |
| GSM8288614 |
Mouse, BIO300-Low, Day1_33 |
| GSM8288615 |
Mouse, BIO300-Low, Day1_34 |
| GSM8288616 |
Mouse, BIO300-Low, Day1_35 |
| GSM8288617 |
Mouse, BIO300-Low, Day1_36 |
| GSM8288618 |
Mouse, BIO300-Med, Day1_37 |
| GSM8288619 |
Mouse, BIO300-Med, Day1_38 |
| GSM8288620 |
Mouse, BIO300-Med, Day1_39 |
| GSM8288621 |
Mouse, BIO300-Med, Day1_40 |
| GSM8288622 |
Mouse, BIO300-Med, Day1_41 |
| GSM8288623 |
Mouse, BIO300-Med, Day1_42 |
| GSM8288624 |
Mouse, BIO300-High, Day1_43 |
| GSM8288625 |
Mouse, BIO300-High, Day1_44 |
| GSM8288626 |
Mouse, BIO300-High, Day1_45 |
| GSM8288627 |
Mouse, BIO300-High, Day1_46 |
| GSM8288628 |
Mouse, BIO300-High, Day1_47 |
| GSM8288629 |
Mouse, BIO300-High, Day1_48 |
| GSM8288630 |
Mouse, Vehicle, TBI, Day1_49 |
| GSM8288631 |
Mouse, Vehicle, TBI, Day1_50 |
| GSM8288632 |
Mouse, Vehicle, TBI, Day1_51 |
| GSM8288633 |
Mouse, Vehicle, TBI, Day1_52 |
| GSM8288634 |
Mouse, Vehicle, TBI, Day1_53 |
| GSM8288635 |
Mouse, Vehicle, TBI, Day1_54 |
| GSM8288636 |
Mouse, BIO300-High, TBI, Day 1_55 |
| GSM8288637 |
Mouse, BIO300-High, TBI, Day 1_56 |
| GSM8288638 |
Mouse, BIO300-High, TBI, Day 1_57 |
| GSM8288639 |
Mouse, BIO300-High, TBI, Day 1_58 |
| GSM8288640 |
Mouse, BIO300-High, TBI, Day 1_59 |
| GSM8288641 |
Mouse, BIO300-High, TBI, Day 1_60 |
|
| Relations |
| BioProject |
PRJNA1115786 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE268247_3vs1_Differential_expression_analysis_table.csv.gz |
1.9 Mb |
(ftp)(http) |
CSV |
| GSE268247_3vs1_raw_counts.csv.gz |
660.5 Kb |
(ftp)(http) |
CSV |
| GSE268247_3vs2_Differential_expression_analysis_table.csv.gz |
1.7 Mb |
(ftp)(http) |
CSV |
| GSE268247_3vs2_raw_counts.csv.gz |
646.7 Kb |
(ftp)(http) |
CSV |
| GSE268247_3vs4_Differential_expression_analysis_table.csv.gz |
1.8 Mb |
(ftp)(http) |
CSV |
| GSE268247_3vs4_raw_counts.csv.gz |
638.9 Kb |
(ftp)(http) |
CSV |
| GSE268247_3vs5_Differential_expression_analysis_table.csv.gz |
1.9 Mb |
(ftp)(http) |
CSV |
| GSE268247_3vs5_raw_counts.csv.gz |
654.8 Kb |
(ftp)(http) |
CSV |
| GSE268247_3vs9_Differential_expression_analysis_table.csv.gz |
1.9 Mb |
(ftp)(http) |
CSV |
| GSE268247_3vs9_raw_counts.csv.gz |
653.0 Kb |
(ftp)(http) |
CSV |
| GSE268247_5vs6_Differential_expression_analysis_table.csv.gz |
1.9 Mb |
(ftp)(http) |
CSV |
| GSE268247_5vs6_raw_counts.csv.gz |
653.7 Kb |
(ftp)(http) |
CSV |
| GSE268247_5vs7_Differential_expression_analysis_table.csv.gz |
1.8 Mb |
(ftp)(http) |
CSV |
| GSE268247_5vs7_raw_counts.csv.gz |
622.9 Kb |
(ftp)(http) |
CSV |
| GSE268247_5vs8_Differential_expression_analysis_table.csv.gz |
1.8 Mb |
(ftp)(http) |
CSV |
| GSE268247_5vs8_raw_counts.csv.gz |
616.6 Kb |
(ftp)(http) |
CSV |
| GSE268247_5vs9_Differential_expression_analysis_table.csv.gz |
2.0 Mb |
(ftp)(http) |
CSV |
| GSE268247_5vs9_raw_counts.csv.gz |
663.1 Kb |
(ftp)(http) |
CSV |
| GSE268247_9vs10_Differential_expression_analysis_table.csv.gz |
1.8 Mb |
(ftp)(http) |
CSV |
| GSE268247_9vs10_raw_counts.csv.gz |
655.7 Kb |
(ftp)(http) |
CSV |
SRA Run Selector |
| Raw data are available in SRA |
|
|
|
|
 |
Less...
More...